Cargando…
The Role of the Reactive Oxygen Species Scavenger Agent, Astaxanthin, in the Protection of Cisplatin-Treated Patients Against Hearing Loss
Emerging evidence of significant hearing loss occurring shortly after cisplatin administration in cancer patients has stimulated research into the causes and treatment of this side effect. Although the aetiology of cisplatin-induced hearing loss (CIHL) remains unknown, an increasing body of research...
Autores principales: | Nan, Benyu, Gu, Xi, Huang, Xinsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927222/ https://www.ncbi.nlm.nih.gov/pubmed/31908415 http://dx.doi.org/10.2147/DDDT.S212313 |
Ejemplares similares
-
Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
por: Nan, Benyu, et al.
Publicado: (2022) -
Scavenging of reactive oxygen species by astaxanthin inhibits epithelial–mesenchymal transition in high glucose-stimulated mesothelial cells
por: Hara, Kazuaki, et al.
Publicado: (2017) -
Aflatoxins are natural scavengers of reactive oxygen species
por: Finotti, E., et al.
Publicado: (2021) -
Reactive Oxygen Species, Apoptosis, and Mitochondrial Dysfunction in Hearing Loss
por: Kamogashira, Teru, et al.
Publicado: (2015) -
Reactive-oxygen-species-scavenging nanomaterials for resolving inflammation
por: Huang, X., et al.
Publicado: (2021)